FDA Inspection 1301216 — Aizant Drug Research Solutions Private Ltd.
The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on November 14, 2025 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 14, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Bioanalytical BA/BE